Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07843862
PHASE2

A Study of HRS-4729 Injection in Participants With Type 2 Diabetes

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate the efficacy and safety of HRS-4729 Injection in participants with type 2 diabetes who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin.

Official title: A Phase II, Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group Clinical Trial Evaluating the Efficacy and Safety of HRS-4729 Injection in Participants With Type 2 Diabetes

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

240

Start Date

2026-10

Completion Date

2027-07

Last Updated

2026-09-28

Healthy Volunteers

No

Conditions

Interventions

DRUG

HRS-4729 Injection

HRS-4729 Injection

DRUG

Mazdutide

Mazdutide

DRUG

Placebo

Placebo

Locations (2)

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

Wuhan, Hubei, China

Tianjin Medical University Chu Hsien-I Memorial Hospital

Tianjin, Tianjin Municipality, China